Protenus Secures Fifth Patent for Drug Diversion Surveillance Technology
BALTIMORE, October 26, 2023 (VSNewsNetwork.com) - Healthcare compliance analytics provider Protenus announced the acquisition of its fifth patent related to drug diversion surveillance technology. The U.S. Patent No. 11,791,029, granted on October 17, 2023, is titled “METHODS AND SYSTEMS FOR ANALYZING ACCESSING OF DRUG DISPENSING SYSTEMS.” This latest addition to Protenus' patent portfolio broadens the scope of techniques used for detecting anomalous drug dispensing activities.
The newly issued patent is primarily aimed at identifying potential drug misappropriation based on the analysis of dispensing patterns among multiple healthcare employees. It facilitates alert notifications at a service layer for potential drug misappropriation events. Protenus' expanding portfolio now includes several U.S. patents that focus on various critical aspects of patient privacy monitoring and drug diversion surveillance, as well as other pending patent applications in the U.S. and abroad.
For additional information, visit www.protenus.com.
Source: Protenus via Newswire
